US Map / Colorado
State CO

Clinical Trials in Colorado

Colorado is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Colorado and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.

Right now ClinicalMetric tracks 278 actively recruiting studies with Colorado sites out of 278 registered in total. The busiest research areas in Colorado are Advanced Solid Tumor, Breast Cancer, Carcinoma, Non-Small-Cell Lung. Leading sponsors running trials in the state include University of Colorado, Denver, Merck Sharp & Dohme LLC, National Cancer Institute (NCI). By stage, Colorado trials break down as Phase 1 (53), Phase 2 (84), Phase 3 (71), Phase 4 (5).

All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.

Total Trials
278
Recruiting Now
278
← Back to US Map
Top Conditions in Colorado
Advanced Solid Tumor (5)Breast Cancer (4)Carcinoma, Non-Small-Cell Lung (4)Malignant Neoplasm (3)Multiple Myeloma (3)B Acute Lymphoblastic Leukemia (3)Metastatic Breast Cancer (3)Kidney Diseases (3)Pancreatic Ductal Adenocarcinoma (3)Pulmonary Hypertension (3)Alzheimer Disease (3)Type 1 Diabetes (3)

Frequently Asked Questions — Clinical Trials in Colorado

How many clinical trials are currently recruiting in Colorado?
ClinicalMetric currently tracks 278 actively recruiting clinical trials with at least one location in Colorado. The total number of registered studies—including active but not currently enrolling trials—is 278. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Colorado?
Colorado hosts clinical trials across a broad range of medical conditions, including Advanced Solid Tumor, Breast Cancer, Carcinoma, Non-Small-Cell Lung, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Colorado serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Colorado?
To join a clinical trial in Colorado, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Colorado maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.

Recruiting Trials in Colorado

NCT07187531 Phase 2
Recruiting
SAFety and Efficacy of Human Anti-thymocyte ImmunoGlobUlin SAB-142 ARresting Pro...
Condition
Type 1 Diabetes
Enrollment
159 pts
Location
United States, Australia, Austria
Sponsor
SAb Biotherapeutics, Inc.
View Trial →
NCT07061977 Phase 3
Recruiting
Induction Pembrolizumab and Chemotherapy Followed by Pembrolizumab Before Chemor...
Condition
Locally Advanced Cervical Adenocarcinoma
Enrollment
336 pts
Location
United States, Puerto Rico
Sponsor
National Cancer Institute (NCI
View Trial →
NCT07614776 Phase 3
Recruiting
A Study to Evaluate Efficacy, Safety, and Immunogenicity With ABP 938 8 mg Versu...
Condition
Neovascular Age-related Macular Degeneration
Enrollment
304 pts
Location
United States, Latvia, Poland
Sponsor
Amgen
View Trial →
NCT06120283 Phase 1
Recruiting
BGB-43395 Alone or as Part of Combination Therapies in Participants With Breast ...
Condition
Advanced Solid Tumor
Enrollment
433 pts
Location
United States, Australia, Brazil
Sponsor
BeOne Medicines
View Trial →
NCT04726241 Phase 1, Phase 2
Recruiting
The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marr...
Condition
Acute Lymphoblastic Leukemia
Enrollment
960 pts
Location
United States, Australia, Canada
Sponsor
PedAL BCU, LLC
View Trial →
NCT07455383 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolep...
Condition
Narcolepsy Type 1
Enrollment
150 pts
Location
United States, Australia, Belgium
Sponsor
Alkermes, Inc.
View Trial →
NCT05978141 N/A
Recruiting
A Registry for People With T-cell Lymphoma
Condition
T-cell Lymphoma
Enrollment
1,000 pts
Location
United States
Sponsor
Memorial Sloan Kettering Cance
View Trial →
NCT07577856 Phase 3
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Ulcer...
Condition
Colitis, Ulcerative
Enrollment
644 pts
Location
United States, Argentina, Australia
Sponsor
Janssen Research & Development
View Trial →
NCT06664775 Phase 3
Recruiting
A Study to Compare the Efficacy and Safety of TachoSil and Surgicel Original as ...
Condition
Hemorrhage
Enrollment
116 pts
Location
United States
Sponsor
Corza Medical GmbH
View Trial →
NCT05732831 Phase 1, Phase 2
Recruiting
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
Condition
Locally Advanced Solid Tumor
Enrollment
225 pts
Location
United States, France, Spain
Sponsor
Tango Therapeutics, Inc.
View Trial →
NCT01073475 N/A
Recruiting
Maternal Newborn Health Registry
Condition
Pregnancy Outcome Trends in Low-resource Geographic Areas
Enrollment
950,000 pts
Location
United States, Bangladesh, Democratic Republic of the Congo
Sponsor
NICHD Global Network for Women
View Trial →
NCT01120353 N/A
Recruiting
Childhood Cancer Survivor Study
Condition
Cancer
Enrollment
50,000 pts
Location
United States, Canada
Sponsor
St. Jude Children's Research H
View Trial →
NCT06011551 N/A
Recruiting
HYDRAFIL-D: HYDRogel Augmentation For Intervertebral Lumbar Discs
Condition
Degenerative Disc Disease (DDD)
Enrollment
225 pts
Location
United States, Canada
Sponsor
ReGelTec, Inc.
View Trial →
NCT06958328 Phase 3
Recruiting
Testing Higher Dose Radiation Therapy for Locally Advanced Pancreatic Cancer
Condition
Locally Advanced Unresectable Pancreatic Ductal Adenocarcinoma
Enrollment
356 pts
Location
United States, Canada
Sponsor
NRG Oncology
View Trial →
NCT06805695 N/A
Recruiting
Long-term Follow-up (LTFU) Study of Participants in Any iECURE Protocol Using an...
Condition
Ornithine Transcarbamylase Deficiency
Enrollment
13 pts
Location
United States, United Kingdom
Sponsor
iECURE, Inc.
View Trial →
NCT07029581 Phase 2
Recruiting
Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis
Condition
Lewy Body Dementia Psychosis
Enrollment
180 pts
Location
United States, Bulgaria, Czechia
Sponsor
ACADIA Pharmaceuticals Inc.
View Trial →
NCT05425992 N/A
Recruiting
Improving Communication and Building a Stronger Medical Home Among Spanish-speak...
Condition
Leukemia
Enrollment
20 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT07175038 Phase 2
Recruiting
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pu...
Condition
Pulmonary Arterial Hypertension (PAH)
Enrollment
40 pts
Location
United States, Australia, Canada
Sponsor
AllRock Bio, Inc.
View Trial →
NCT06598943 Phase 2
Recruiting
A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Seve...
Condition
Ulcerative Colitis
Enrollment
143 pts
Location
United States, Argentina, Belgium
Sponsor
Eli Lilly and Company
View Trial →
NCT07081698 N/A
Recruiting
Walnuts as an Infant Solid Food for Health
Condition
Gut -Microbiota
Enrollment
90 pts
Location
United States
Sponsor
Colorado State University
View Trial →
NCT04071847 N/A
Recruiting
Abbott DBS Post-Market Study of Outcomes for Indications Over Time
Condition
Movement Disorders
Enrollment
1,000 pts
Location
United States, Australia, Finland
Sponsor
Abbott Medical Devices
View Trial →
NCT07205887 Phase 2
Recruiting
A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular...
Condition
Neovascular Age-Related Macular Degeneration (NVAMD)
Enrollment
160 pts
Location
United States
Sponsor
EyeBiotech Ltd.
View Trial →
NCT03900793 Phase 1
Recruiting
Losartan + Sunitinib in Treatment of Osteosarcoma
Condition
Osteosarcoma
Enrollment
41 pts
Location
United States
Sponsor
University of Colorado, Denver
View Trial →
NCT05764733 Phase 4
Recruiting
Bone, Exercise, Alendronate, and Caloric Restriction
Condition
Bone Loss
Enrollment
900 pts
Location
United States
Sponsor
Wake Forest University Health
View Trial →
NCT07076485 Phase 2
Recruiting
Shortening Adjuvant Photon and Proton Irradiation (SAPPHIRe-II): A 4 Cohort, Ran...
Condition
Breast Cancer
Enrollment
768 pts
Location
United States
Sponsor
M.D. Anderson Cancer Center
View Trial →
Page 9 of 12 — 278 trials total
← Prev Next →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: September 2026  ·  Data Methodology